Abstract
As most Update readers are aware, the U.S. Food and Drug Administration (FDA) has approved only one drug with an indication for treatment‐resistant schizophrenia: clozapine. You might not know the backstory to this though.
Subject
Cardiology and Cardiovascular Medicine,General Medicine